IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Dr. Reddy’s and GSK Form Alliance in Emerging Markets

8:44 AM MDT | June 29, 2009 | DEEPTI RAMESH

Dr. Reddy’s Laboratories (Hyderabad, India) says it has entered into an agreement with GlaxoSmithKline (GSK; London) to develop and market select products in several emerging markets, excluding India. Financial terms of the deal were not disclosed. Hussain: Demand for drugs rising in some regions. Dr. Reddy’s says this is the first such alliance between the two companies. The deal calls for GSK to gain exclusive access to Dr. Reddy’s portfolio and future pipeline of more than 100 branded pharmaceuticals in fast-growing therapeutic segments such...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa